X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (180) 180
index medicus (167) 167
drug-naive patients (146) 146
male (115) 115
psychiatry (103) 103
animals (99) 99
neurosciences (98) 98
schizophrenia (98) 98
pharmacology & pharmacy (85) 85
drug-naive (82) 82
female (82) 82
double-blind (57) 57
glucagon-like peptide-1 (57) 57
adult (56) 56
diabetes mellitus, type 2 - drug therapy (56) 56
endocrinology & metabolism (53) 53
type 2 diabetes (51) 51
clinical neurology (49) 49
rats (44) 44
beta-cell function (39) 39
diabetes (39) 39
improves glycemic control (37) 37
brain (36) 36
hypoglycemic agents - therapeutic use (36) 36
middle aged (36) 36
dipeptidyl peptidase-4 inhibitor (34) 34
analysis (33) 33
glucose (32) 32
treatment outcome (30) 30
dipeptidyl-peptidase iv inhibitors - therapeutic use (29) 29
mice (28) 28
vildagliptin (28) 28
research (26) 26
care and treatment (25) 25
insulin-resistance (25) 25
metabolic syndrome (25) 25
risk factors (25) 25
schizophrenia - blood (25) 25
dopamine (24) 24
schizophrenia - drug therapy (24) 24
glycemic control (22) 22
review (22) 22
schizophrenia - metabolism (22) 22
sitagliptin (22) 22
drug therapy (21) 21
type-2 diabetes-mellitus (21) 21
antipsychotic agents - therapeutic use (20) 20
atypical antipsychotics (20) 20
blood glucose - metabolism (20) 20
hypoglycemic agents (20) 20
insulin (20) 20
adamantane - analogs & derivatives (19) 19
glp-1 (19) 19
glucose-tolerance (19) 19
iv inhibitor (19) 19
physiological aspects (19) 19
case-control studies (18) 18
diabetes therapy (18) 18
dpp-4 inhibitor (18) 18
metformin-treated patients (18) 18
aged (17) 17
diabetes mellitus, type 2 - metabolism (17) 17
dipeptidyl peptidase-4 (17) 17
disease models, animal (17) 17
drug therapy, combination (17) 17
health aspects (17) 17
insulin resistance (17) 17
internal medicine (17) 17
nucleus-accumbens (17) 17
prefrontal cortex (17) 17
self administration (17) 17
adolescent (16) 16
dextrose (16) 16
initial combination therapy (16) 16
mental disorders (16) 16
oxidative stress (16) 16
rats, wistar (16) 16
young adult (16) 16
antipsychotic drugs (15) 15
biochemistry & molecular biology (15) 15
diabetes mellitus, type 2 - blood (15) 15
diagnosis (15) 15
dipeptidyl-peptidase iv inhibitors - adverse effects (15) 15
dose-response relationship, drug (15) 15
psychosis (15) 15
1st-episode (14) 14
adamantane - therapeutic use (14) 14
cocaine (14) 14
depression (14) 14
diabetes mellitus (14) 14
medical research (14) 14
neurology (14) 14
schizophrenia - physiopathology (14) 14
self-administration (14) 14
brain - metabolism (13) 13
drug-naive mice (13) 13
efficacy (13) 13
glucose metabolism (13) 13
hypoglycemic agents - adverse effects (13) 13
medicine & public health (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Behavioural Brain Research, ISSN 0166-4328, 03/2011, Volume 217, Issue 2, pp. 337 - 346
▶ An animal model of olanzapine-induced obesity by oral self-administration (three times/day). ▶ Self-administration of olanzapine mixed with food, given at... 
Animal model | Metabolic side-effect | Antipsychotic | Olanzapine | Weight gain | Dose | MESSENGER-RNA EXPRESSION | FOOD-INTAKE | INSULIN-SECRETION | DRUG-NAIVE | NEUROSCIENCES | DORSAL VAGAL COMPLEX | BODY-WEIGHT | ATYPICAL ANTIPSYCHOTIC OLANZAPINE | DOUBLE-BLIND | BEHAVIORAL SCIENCES | ANIMAL-MODEL | INDUCED WEIGHT-GAIN | Body weight | Cholecystokinin
Journal Article
Behavioural Pharmacology, ISSN 0955-8810, 2002, Volume 13, Issue 5-6, pp. 451 - 463
Journal Article
Journal Article
Molecular Neurobiology, ISSN 0893-7648, 10/2017, Volume 54, Issue 8, pp. 5741 - 5751
Journal Article
Journal Article
Journal Article
Drug and Alcohol Dependence, ISSN 0376-8716, 2011, Volume 122, Issue 1, pp. 152 - 155
Journal Article